In focus · trending topic

Drug Development

62 stories · following the connections

Atlant Clinical to host first MedDRA Face-to-Face Trainings in Russia

By Nasdaq OMXMay 31, 2017, 4:51 PM UTC

CURE Pharmaceutical and CannaKids Announce Research Collaboration with Technion-Israel Institute of Technology on Cancer-Fighting Cannabinoids

By Nasdaq OMXMay 31, 2017, 1:04 PM UTC

CURE Pharmaceutical and CannaKids Announce Research Collaboration with Technion-Israel Institute of Technology on Cancer-Fighting Cannabinoids

By Nasdaq OMXMay 31, 2017, 1:04 PM UTC

CURE Pharmaceutical and CannaKids Announce Research Collaboration with Technion-Israel Institute of Technology on Cancer-Fighting Cannabinoids

By Nasdaq OMXMay 31, 2017, 1:04 PM UTC

CURE Pharmaceutical and CannaKids Announce Research Collaboration with Technion-Israel Institute of Technology on Cancer-Fighting Cannabinoids

By Nasdaq OMXMay 31, 2017, 1:04 PM UTC

GeneCentric Therapeutics Appoints Walter M. Capone as Chief Business Officer and Adds Ellen Lubman to Board of Directors as Company Advances Drug Development Platform

By Nasdaq OMXMay 30, 2017, 11:03 AM UTC

GeneCentric Therapeutics Appoints Walter M. Capone as Chief Business Officer and Adds Ellen Lubman to Board of Directors as Company Advances Drug Development Platform

By Nasdaq OMXMay 30, 2017, 11:03 AM UTC

GeneCentric Therapeutics Appoints Walter M. Capone as Chief Business Officer and Adds Ellen Lubman to Board of Directors as Company Advances Drug Development Platform

By Nasdaq OMXMay 30, 2017, 11:03 AM UTC